Pharma Unplugged: FDA Social Media Hearing
A Link Apart : FDA Social Media Hearing
Pharma Unplugged Podcast Series
Download Adobe Flash Player
Sponsors
Patient Segmentation Strategies
WEBCAST – Sponsor (Medpoint)
How Virtual Media Can Save the Medical Speaker Program
WEBCAST – Sponsor (Healthgrades)
Driving Medication Compliance
PODCAST – Sponsor (AdherenceRx)
Topic:
(Nov 23, 2009) Think you’ve heard enough about the FDA Social Media Hearing held earlier this month. Granted, the gaggle of general and industry coverage was way more than one person can digest. So we asked four experts who spoke at the hearings to sit down with us and debate the issues. With so much at stake and so little clarity, we hope this hour long panel interview will help you figure out what it all means to you and your business.
Host:
George Koroneos, Online/News Editor: Pharmaceutical Executive
Panel:
Fabio Gratton, founder, Ignite Health
Fard Johnmar, founder, Envision Solutions
Bruce Grant, SVP, Business Strategy, Digitas Health
Bill Drummy, founder and CEO, Heartbeat Digital
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
Optimizing Phase III Oncology Trial Recruitment with Data-Driven Insights
February 3rd 2025A pharmaceutical company aimed to launch a Phase III clinical trial for a new oncology drug, focusing on efficient and effective patient recruitment across diverse regions. They evaluated patient populations by analyzing demographics, social determinants of health, and geography. Investigator profiling included practice details, affiliations, referral networks, and clinical trial experience. The final step involved selecting and extracting target lists for implementation.
